Glucomet tablets are a combination medication primarily containing Glibenclamide 5mg and Metformin Hydrochloride 500mg. These active pharmaceutical ingredients are formulated together to manage specific health conditions.
Active Ingredients of Glucomet
Each Glucomet tablet is precisely formulated with two key components:
| Ingredient | Quantity per Tablet | Role |
|---|---|---|
| Glibenclamide | 5 mg | Sulfonylurea (type of antidiabetic) |
| Metformin Hydrochloride | 500 mg | Biguanide (type of antidiabetic) |
Physical Characteristics
Glucomet tablets are designed for oral administration. They are light yellow, capsule-shaped, and biconvex. Each tablet is film-coated and embossed with 'COSMOS' on one side and a breakline on the other. This distinct appearance aids in identification.
Understanding the Components
The combination of Glibenclamide and Metformin Hydrochloride in Glucomet offers a dual-action approach, leveraging the benefits of both compounds:
- Glibenclamide (5mg): This belongs to a class of drugs known as sulfonylureas. It works by stimulating the pancreas to release more insulin. Insulin is a hormone crucial for regulating blood glucose (sugar) levels. By increasing insulin secretion, Glibenclamide helps reduce high blood sugar.
- Metformin Hydrochloride (500mg): As a biguanide, Metformin primarily works by decreasing glucose production in the liver and improving the body's sensitivity to insulin. This means the body's cells are better able to take up glucose from the blood. Unlike Glibenclamide, Metformin does not directly stimulate insulin secretion, which can reduce the risk of certain side effects like hypoglycemia (low blood sugar) when used alone.
The synergistic effect of these two ingredients provides comprehensive blood sugar control.
